Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug
Outsourcing-Pharma
by
9h ago
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition ..read more
Visit website
Pfizer’s HYMPAVZI for Hemophilia A or B receives EU approval
Outsourcing-Pharma
by
1d ago
The European Commission has approved Pfizerâs treatment for adults and adolescents with severe hemophilia A or B ..read more
Visit website
Samsung Biologics and European pharma company enter major manufacturing deal
Outsourcing-Pharma
by
1d ago
The global CDMO has entered into several high-value manufacturing deals this year ..read more
Visit website
Helen Harrington’s journey: Patience, passion, and problem-solving
Outsourcing-Pharma
by
1d ago
From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harringtonâs journey is one of resilience and curiosity ..read more
Visit website
Tran Pham: Breaking barriers and building biopharma solutions
Outsourcing-Pharma
by
1d ago
From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has built a dynamic career in biopharma ..read more
Visit website
Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease
Outsourcing-Pharma
by
2d ago
Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults ..read more
Visit website
C Ray Therapeutics raises $100 million to develop radiopharmaceuticals
Outsourcing-Pharma
by
2d ago
The financing round will fund the improvement of the companyâs technology platform for the discovery and development of innovative radionuclide drug conjugates ..read more
Visit website
Genesis Therapeutics expands AI drug discovery collaboration with $200M funding
Outsourcing-Pharma
by
1w ago
Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIAâs venture capital arm ..read more
Visit website
AstraZeneca doubles down on US manufacturing with $3.5 billion investment
Outsourcing-Pharma
by
1w ago
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites ..read more
Visit website
Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years
Outsourcing-Pharma
by
1w ago
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to type 2 diabetes in 99% of participants ..read more
Visit website

Follow Outsourcing-Pharma on FeedSpot

Continue with Google
Continue with Apple
OR